These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 9847513

  • 1. [Discrepancy between 99mTc-HMPAO and 99mTc-ECD in Alzheimer's disease: does the retention mechanism depend on the disease?].
    Komatani A, Sugai Y, Watanabe N, Yamaguchi K, Kawakatsu S.
    Kaku Igaku; 1998 Oct; 35(8):715-20. PubMed ID: 9847513
    [Abstract] [Full Text] [Related]

  • 2. [Investigation of discrepancy between 99mTc-HMPAO and 133Xe rCBF SPECT; a comparative study with X-ray CT findings].
    Komatani A, Akutsu T, Onodera Y, Yamaguchi K.
    Kaku Igaku; 1995 Sep; 32(9):989-96. PubMed ID: 8523847
    [Abstract] [Full Text] [Related]

  • 3. Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease.
    van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB.
    J Nucl Med; 1996 Nov; 37(11):1749-55. PubMed ID: 8917168
    [Abstract] [Full Text] [Related]

  • 4. Development of "super rapid dynamic SPECT," and analysis of retention process of 99mTc-ECD in ischemic lesions: comparative study with 133Xe SPECT.
    Komatani A, Sugai Y, Hosoya T.
    Ann Nucl Med; 2004 Sep; 18(6):489-94. PubMed ID: 15515748
    [Abstract] [Full Text] [Related]

  • 5. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates.
    Dormehl IC, Oliver DW, Langen KJ, Hugo N, Croft SA.
    J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 99mTc-HMPAO and 99mTc-ECD brain uptake correlates of verbal memory in Alzheimer's disease.
    Nobili F, Koulibaly PM, Rodriguez G, Benoit M, Girtler N, Robert PH, Brugnolo A, Darcourt J.
    Q J Nucl Med Mol Imaging; 2007 Dec; 51(4):357-63. PubMed ID: 17220817
    [Abstract] [Full Text] [Related]

  • 8. 99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease.
    Koulibaly PM, Nobili F, Migneco O, Vitali P, Robert PH, Girtler N, Darcourt J, Rodriguez G.
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1009-13. PubMed ID: 12750851
    [Abstract] [Full Text] [Related]

  • 9. Technetium-99m-ECD SPECT fails to show focal hyperemia of acute herpes encephalitis.
    Fazekas F, Roob G, Payer F, Kapeller P, Strasser-Fuchs S, Aigner RM.
    J Nucl Med; 1998 May; 39(5):790-2. PubMed ID: 9591576
    [Abstract] [Full Text] [Related]

  • 10. A quantitative approach to technetium-99m ethyl cysteinate dimer: a comparison with technetium-99m hexamethylpropylene amine oxime.
    Matsuda H, Yagishita A, Tsuji S, Hisada K.
    Eur J Nucl Med; 1995 Jul; 22(7):633-7. PubMed ID: 7498224
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects.
    Léveillé J, Demonceau G, Walovitch RC.
    J Nucl Med; 1992 Apr; 33(4):480-4. PubMed ID: 1552328
    [Abstract] [Full Text] [Related]

  • 13. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison.
    Asenbaum S, Brücke T, Pirker W, Pietrzyk U, Podreka I.
    J Nucl Med; 1998 Apr; 39(4):613-8. PubMed ID: 9544665
    [Abstract] [Full Text] [Related]

  • 14. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
    Inoue K, Nakagawa M, Goto R, Kinomura S, Sato T, Sato K, Fukuda H.
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD.
    Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H.
    J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207
    [Abstract] [Full Text] [Related]

  • 17. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe.
    Oku N, Matsumoto M, Hashikawa K, Moriwaki H, Ishida M, Seike Y, Terakawa H, Watanabe Y, Uehara T, Nishimura T.
    J Nucl Med; 1997 Jul; 38(7):1109-11. PubMed ID: 9225799
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of cerebral vasoreactivity to acetazolamide in normal volunteer among 123I-IMP, 99mTc-ECD and 99mTc-HMPAO].
    Makino K, Masuda Y, Gotoh S.
    Kaku Igaku; 1996 May; 33(5):551-5. PubMed ID: 8699624
    [Abstract] [Full Text] [Related]

  • 19. A discrepancy between Tc-99m HMPAO SPECT and Tc-99m ECD SPECT in Creutzfeldt-Jacob disease.
    Sunada I, Ishida T, Sakamoto S, Tsuyuguchi N.
    J Clin Neurosci; 2004 Aug; 11(6):648-50. PubMed ID: 15261242
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.